nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Convulsion—Mitoxantrone—sarcoma	0.00276	0.00276	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00275	0.00275	CcSEcCtD
Gadodiamide—Abnormal vision—Doxorubicin—sarcoma	0.00275	0.00275	CcSEcCtD
Gadodiamide—Chills—Etoposide—sarcoma	0.00274	0.00274	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00273	0.00273	CcSEcCtD
Gadodiamide—Arthralgia—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Gadodiamide—Myalgia—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Gadodiamide—Chest pain—Mitoxantrone—sarcoma	0.00272	0.00272	CcSEcCtD
Gadodiamide—Paraesthesia—Thiotepa—sarcoma	0.00271	0.00271	CcSEcCtD
Gadodiamide—Anxiety—Mitoxantrone—sarcoma	0.00271	0.00271	CcSEcCtD
Gadodiamide—Discomfort—Mitoxantrone—sarcoma	0.00268	0.00268	CcSEcCtD
Gadodiamide—Somnolence—Thiotepa—sarcoma	0.00268	0.00268	CcSEcCtD
Gadodiamide—Renal failure acute—Epirubicin—sarcoma	0.00268	0.00268	CcSEcCtD
Gadodiamide—Oedema—Vincristine—sarcoma	0.00267	0.00267	CcSEcCtD
Gadodiamide—Anaphylactic shock—Vincristine—sarcoma	0.00267	0.00267	CcSEcCtD
Gadodiamide—Infection—Vincristine—sarcoma	0.00266	0.00266	CcSEcCtD
Gadodiamide—Dyspepsia—Thiotepa—sarcoma	0.00265	0.00265	CcSEcCtD
Gadodiamide—Phlebitis—Doxorubicin—sarcoma	0.00265	0.00265	CcSEcCtD
Gadodiamide—Hot flush—Epirubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Gadodiamide—Nervous system disorder—Vincristine—sarcoma	0.00262	0.00262	CcSEcCtD
Gadodiamide—Menopausal symptoms—Epirubicin—sarcoma	0.00262	0.00262	CcSEcCtD
Gadodiamide—Anaphylactic shock—Mitoxantrone—sarcoma	0.0026	0.0026	CcSEcCtD
Gadodiamide—Oedema—Mitoxantrone—sarcoma	0.0026	0.0026	CcSEcCtD
Gadodiamide—Fatigue—Thiotepa—sarcoma	0.0026	0.0026	CcSEcCtD
Gadodiamide—Dysgeusia—Etoposide—sarcoma	0.0026	0.0026	CcSEcCtD
Gadodiamide—Renal impairment—Epirubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Gadodiamide—Infection—Mitoxantrone—sarcoma	0.00259	0.00259	CcSEcCtD
Gadodiamide—Hyperhidrosis—Vincristine—sarcoma	0.00258	0.00258	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—sarcoma	0.00258	0.00258	CcSEcCtD
Gadodiamide—Pain—Thiotepa—sarcoma	0.00258	0.00258	CcSEcCtD
Gadodiamide—Shock—Mitoxantrone—sarcoma	0.00256	0.00256	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—sarcoma	0.00256	0.00256	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Epirubicin—sarcoma	0.00255	0.00255	CcSEcCtD
Gadodiamide—Tachycardia—Mitoxantrone—sarcoma	0.00254	0.00254	CcSEcCtD
Gadodiamide—Cardiac failure—Epirubicin—sarcoma	0.00253	0.00253	CcSEcCtD
Gadodiamide—Hyperhidrosis—Mitoxantrone—sarcoma	0.00252	0.00252	CcSEcCtD
Gadodiamide—Hypotension—Vincristine—sarcoma	0.0025	0.0025	CcSEcCtD
Gadodiamide—Feeling abnormal—Thiotepa—sarcoma	0.00248	0.00248	CcSEcCtD
Gadodiamide—Hyponatraemia—Epirubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Gadodiamide—Renal failure acute—Doxorubicin—sarcoma	0.00248	0.00248	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—sarcoma	0.00247	0.00247	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Thiotepa—sarcoma	0.00247	0.00247	CcSEcCtD
Gadodiamide—Ill-defined disorder—Etoposide—sarcoma	0.00246	0.00246	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—sarcoma	0.00245	0.00245	CcSEcCtD
Gadodiamide—Hot flush—Doxorubicin—sarcoma	0.00244	0.00244	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vincristine—sarcoma	0.00244	0.00244	CcSEcCtD
Gadodiamide—Hypotension—Mitoxantrone—sarcoma	0.00243	0.00243	CcSEcCtD
Gadodiamide—Migraine—Epirubicin—sarcoma	0.00243	0.00243	CcSEcCtD
Gadodiamide—Menopausal symptoms—Doxorubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Gadodiamide—Renal impairment—Doxorubicin—sarcoma	0.0024	0.0024	CcSEcCtD
Gadodiamide—Paraesthesia—Vincristine—sarcoma	0.0024	0.0024	CcSEcCtD
Gadodiamide—Urticaria—Thiotepa—sarcoma	0.0024	0.0024	CcSEcCtD
Gadodiamide—Malaise—Etoposide—sarcoma	0.00239	0.00239	CcSEcCtD
Gadodiamide—Abdominal pain—Thiotepa—sarcoma	0.00238	0.00238	CcSEcCtD
Gadodiamide—Body temperature increased—Thiotepa—sarcoma	0.00238	0.00238	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00237	0.00237	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—sarcoma	0.00237	0.00237	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—sarcoma	0.00237	0.00237	CcSEcCtD
Gadodiamide—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Gadodiamide—Cardiac failure—Doxorubicin—sarcoma	0.00234	0.00234	CcSEcCtD
Gadodiamide—Paraesthesia—Mitoxantrone—sarcoma	0.00234	0.00234	CcSEcCtD
Gadodiamide—Loss of consciousness—Etoposide—sarcoma	0.00233	0.00233	CcSEcCtD
Gadodiamide—Ataxia—Epirubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Gadodiamide—Dyspnoea—Mitoxantrone—sarcoma	0.00232	0.00232	CcSEcCtD
Gadodiamide—Somnolence—Mitoxantrone—sarcoma	0.00231	0.00231	CcSEcCtD
Gadodiamide—Blood creatinine increased—Epirubicin—sarcoma	0.00231	0.00231	CcSEcCtD
Gadodiamide—Fatigue—Vincristine—sarcoma	0.00231	0.00231	CcSEcCtD
Gadodiamide—Convulsion—Etoposide—sarcoma	0.0023	0.0023	CcSEcCtD
Gadodiamide—Hyponatraemia—Doxorubicin—sarcoma	0.00229	0.00229	CcSEcCtD
Gadodiamide—Dyspepsia—Mitoxantrone—sarcoma	0.00229	0.00229	CcSEcCtD
Gadodiamide—Pain—Vincristine—sarcoma	0.00229	0.00229	CcSEcCtD
Gadodiamide—Chest pain—Etoposide—sarcoma	0.00226	0.00226	CcSEcCtD
Gadodiamide—Migraine—Doxorubicin—sarcoma	0.00225	0.00225	CcSEcCtD
Gadodiamide—Fatigue—Mitoxantrone—sarcoma	0.00224	0.00224	CcSEcCtD
Gadodiamide—Discomfort—Etoposide—sarcoma	0.00223	0.00223	CcSEcCtD
Gadodiamide—Pain—Mitoxantrone—sarcoma	0.00223	0.00223	CcSEcCtD
Gadodiamide—Hypersensitivity—Thiotepa—sarcoma	0.00222	0.00222	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—sarcoma	0.0022	0.0022	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Vincristine—sarcoma	0.00219	0.00219	CcSEcCtD
Gadodiamide—Anaphylactic shock—Etoposide—sarcoma	0.00217	0.00217	CcSEcCtD
Gadodiamide—Asthenia—Thiotepa—sarcoma	0.00216	0.00216	CcSEcCtD
Gadodiamide—Infection—Etoposide—sarcoma	0.00215	0.00215	CcSEcCtD
Gadodiamide—Ataxia—Doxorubicin—sarcoma	0.00215	0.00215	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—sarcoma	0.00215	0.00215	CcSEcCtD
Gadodiamide—Feeling abnormal—Mitoxantrone—sarcoma	0.00215	0.00215	CcSEcCtD
Gadodiamide—Blood creatinine increased—Doxorubicin—sarcoma	0.00214	0.00214	CcSEcCtD
Gadodiamide—Pruritus—Thiotepa—sarcoma	0.00213	0.00213	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Mitoxantrone—sarcoma	0.00213	0.00213	CcSEcCtD
Gadodiamide—Tachycardia—Etoposide—sarcoma	0.00211	0.00211	CcSEcCtD
Gadodiamide—Abdominal pain—Vincristine—sarcoma	0.00211	0.00211	CcSEcCtD
Gadodiamide—Body temperature increased—Vincristine—sarcoma	0.00211	0.00211	CcSEcCtD
Gadodiamide—Hyperhidrosis—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Gadodiamide—Urticaria—Mitoxantrone—sarcoma	0.00207	0.00207	CcSEcCtD
Gadodiamide—Diarrhoea—Thiotepa—sarcoma	0.00206	0.00206	CcSEcCtD
Gadodiamide—Abdominal pain—Mitoxantrone—sarcoma	0.00206	0.00206	CcSEcCtD
Gadodiamide—Body temperature increased—Mitoxantrone—sarcoma	0.00206	0.00206	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—sarcoma	0.00205	0.00205	CcSEcCtD
Gadodiamide—Hypotension—Etoposide—sarcoma	0.00202	0.00202	CcSEcCtD
Gadodiamide—Dizziness—Thiotepa—sarcoma	0.00199	0.00199	CcSEcCtD
Gadodiamide—Hypersensitivity—Vincristine—sarcoma	0.00197	0.00197	CcSEcCtD
Gadodiamide—Paraesthesia—Etoposide—sarcoma	0.00194	0.00194	CcSEcCtD
Gadodiamide—Dyspnoea—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Gadodiamide—Somnolence—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Gadodiamide—Hypersensitivity—Mitoxantrone—sarcoma	0.00192	0.00192	CcSEcCtD
Gadodiamide—Asthenia—Vincristine—sarcoma	0.00192	0.00192	CcSEcCtD
Gadodiamide—Vomiting—Thiotepa—sarcoma	0.00192	0.00192	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—sarcoma	0.0019	0.0019	CcSEcCtD
Gadodiamide—Rash—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Gadodiamide—Dermatitis—Thiotepa—sarcoma	0.0019	0.0019	CcSEcCtD
Gadodiamide—Headache—Thiotepa—sarcoma	0.00189	0.00189	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—sarcoma	0.00189	0.00189	CcSEcCtD
Gadodiamide—Renal failure—Epirubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Gadodiamide—Asthenia—Mitoxantrone—sarcoma	0.00187	0.00187	CcSEcCtD
Gadodiamide—Fatigue—Etoposide—sarcoma	0.00187	0.00187	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Epirubicin—sarcoma	0.00187	0.00187	CcSEcCtD
Gadodiamide—Pain—Etoposide—sarcoma	0.00185	0.00185	CcSEcCtD
Gadodiamide—Diarrhoea—Vincristine—sarcoma	0.00183	0.00183	CcSEcCtD
Gadodiamide—Nausea—Thiotepa—sarcoma	0.00179	0.00179	CcSEcCtD
Gadodiamide—Feeling abnormal—Etoposide—sarcoma	0.00178	0.00178	CcSEcCtD
Gadodiamide—Diarrhoea—Mitoxantrone—sarcoma	0.00178	0.00178	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—sarcoma	0.00178	0.00178	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Etoposide—sarcoma	0.00177	0.00177	CcSEcCtD
Gadodiamide—Dizziness—Vincristine—sarcoma	0.00177	0.00177	CcSEcCtD
Gadodiamide—Renal failure—Doxorubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Doxorubicin—sarcoma	0.00173	0.00173	CcSEcCtD
Gadodiamide—Urticaria—Etoposide—sarcoma	0.00172	0.00172	CcSEcCtD
Gadodiamide—Rhinitis—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Gadodiamide—Body temperature increased—Etoposide—sarcoma	0.00171	0.00171	CcSEcCtD
Gadodiamide—Abdominal pain—Etoposide—sarcoma	0.00171	0.00171	CcSEcCtD
Gadodiamide—Vomiting—Vincristine—sarcoma	0.0017	0.0017	CcSEcCtD
Gadodiamide—Pharyngitis—Epirubicin—sarcoma	0.0017	0.0017	CcSEcCtD
Gadodiamide—Urinary tract disorder—Epirubicin—sarcoma	0.00169	0.00169	CcSEcCtD
Gadodiamide—Rash—Vincristine—sarcoma	0.00169	0.00169	CcSEcCtD
Gadodiamide—Dermatitis—Vincristine—sarcoma	0.00168	0.00168	CcSEcCtD
Gadodiamide—Urethral disorder—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Gadodiamide—Headache—Vincristine—sarcoma	0.00167	0.00167	CcSEcCtD
Gadodiamide—Vomiting—Mitoxantrone—sarcoma	0.00166	0.00166	CcSEcCtD
Gadodiamide—Visual impairment—Epirubicin—sarcoma	0.00165	0.00165	CcSEcCtD
Gadodiamide—Rash—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Gadodiamide—Dermatitis—Mitoxantrone—sarcoma	0.00164	0.00164	CcSEcCtD
Gadodiamide—Headache—Mitoxantrone—sarcoma	0.00163	0.00163	CcSEcCtD
Gadodiamide—Hypersensitivity—Etoposide—sarcoma	0.0016	0.0016	CcSEcCtD
Gadodiamide—Tinnitus—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gadodiamide—Nausea—Vincristine—sarcoma	0.00159	0.00159	CcSEcCtD
Gadodiamide—Flushing—Epirubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gadodiamide—Rhinitis—Doxorubicin—sarcoma	0.00159	0.00159	CcSEcCtD
Gadodiamide—Pharyngitis—Doxorubicin—sarcoma	0.00157	0.00157	CcSEcCtD
Gadodiamide—Urinary tract disorder—Doxorubicin—sarcoma	0.00156	0.00156	CcSEcCtD
Gadodiamide—Asthenia—Etoposide—sarcoma	0.00155	0.00155	CcSEcCtD
Gadodiamide—Urethral disorder—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Gadodiamide—Nausea—Mitoxantrone—sarcoma	0.00155	0.00155	CcSEcCtD
Gadodiamide—Chills—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Gadodiamide—Pruritus—Etoposide—sarcoma	0.00153	0.00153	CcSEcCtD
Gadodiamide—Arrhythmia—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Gadodiamide—Visual impairment—Doxorubicin—sarcoma	0.00152	0.00152	CcSEcCtD
Gadodiamide—Diarrhoea—Etoposide—sarcoma	0.00148	0.00148	CcSEcCtD
Gadodiamide—Tinnitus—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Gadodiamide—Flushing—Doxorubicin—sarcoma	0.00147	0.00147	CcSEcCtD
Gadodiamide—Dysgeusia—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Gadodiamide—Dizziness—Etoposide—sarcoma	0.00143	0.00143	CcSEcCtD
Gadodiamide—Chills—Doxorubicin—sarcoma	0.00142	0.00142	CcSEcCtD
Gadodiamide—Arrhythmia—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Gadodiamide—Ill-defined disorder—Epirubicin—sarcoma	0.00138	0.00138	CcSEcCtD
Gadodiamide—Vomiting—Etoposide—sarcoma	0.00138	0.00138	CcSEcCtD
Gadodiamide—Rash—Etoposide—sarcoma	0.00137	0.00137	CcSEcCtD
Gadodiamide—Dermatitis—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Gadodiamide—Headache—Etoposide—sarcoma	0.00136	0.00136	CcSEcCtD
Gadodiamide—Dysgeusia—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Gadodiamide—Malaise—Epirubicin—sarcoma	0.00134	0.00134	CcSEcCtD
Gadodiamide—Syncope—Epirubicin—sarcoma	0.00133	0.00133	CcSEcCtD
Gadodiamide—Loss of consciousness—Epirubicin—sarcoma	0.00131	0.00131	CcSEcCtD
Gadodiamide—Convulsion—Epirubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Gadodiamide—Nausea—Etoposide—sarcoma	0.00129	0.00129	CcSEcCtD
Gadodiamide—Ill-defined disorder—Doxorubicin—sarcoma	0.00128	0.00128	CcSEcCtD
Gadodiamide—Chest pain—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gadodiamide—Arthralgia—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gadodiamide—Myalgia—Epirubicin—sarcoma	0.00127	0.00127	CcSEcCtD
Gadodiamide—Anxiety—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Gadodiamide—Discomfort—Epirubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Gadodiamide—Malaise—Doxorubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Gadodiamide—Dry mouth—Epirubicin—sarcoma	0.00124	0.00124	CcSEcCtD
Gadodiamide—Syncope—Doxorubicin—sarcoma	0.00123	0.00123	CcSEcCtD
Gadodiamide—Oedema—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gadodiamide—Anaphylactic shock—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gadodiamide—Loss of consciousness—Doxorubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gadodiamide—Infection—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Gadodiamide—Shock—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gadodiamide—Convulsion—Doxorubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gadodiamide—Nervous system disorder—Epirubicin—sarcoma	0.00119	0.00119	CcSEcCtD
Gadodiamide—Tachycardia—Epirubicin—sarcoma	0.00118	0.00118	CcSEcCtD
Gadodiamide—Hyperhidrosis—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gadodiamide—Arthralgia—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gadodiamide—Chest pain—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gadodiamide—Myalgia—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gadodiamide—Anxiety—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Gadodiamide—Discomfort—Doxorubicin—sarcoma	0.00116	0.00116	CcSEcCtD
Gadodiamide—Dry mouth—Doxorubicin—sarcoma	0.00115	0.00115	CcSEcCtD
Gadodiamide—Hypotension—Epirubicin—sarcoma	0.00113	0.00113	CcSEcCtD
Gadodiamide—Oedema—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Gadodiamide—Anaphylactic shock—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Gadodiamide—Infection—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gadodiamide—Shock—Doxorubicin—sarcoma	0.00111	0.00111	CcSEcCtD
Gadodiamide—Nervous system disorder—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Gadodiamide—Tachycardia—Doxorubicin—sarcoma	0.0011	0.0011	CcSEcCtD
Gadodiamide—Paraesthesia—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Gadodiamide—Hyperhidrosis—Doxorubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Gadodiamide—Dyspnoea—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Gadodiamide—Somnolence—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Gadodiamide—Dyspepsia—Epirubicin—sarcoma	0.00107	0.00107	CcSEcCtD
Gadodiamide—Hypotension—Doxorubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gadodiamide—Fatigue—Epirubicin—sarcoma	0.00105	0.00105	CcSEcCtD
Gadodiamide—Pain—Epirubicin—sarcoma	0.00104	0.00104	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Gadodiamide—Paraesthesia—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Gadodiamide—Dyspnoea—Doxorubicin—sarcoma	0.001	0.001	CcSEcCtD
Gadodiamide—Feeling abnormal—Epirubicin—sarcoma	0.001	0.001	CcSEcCtD
Gadodiamide—Somnolence—Doxorubicin—sarcoma	0.000999	0.000999	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Epirubicin—sarcoma	0.000993	0.000993	CcSEcCtD
Gadodiamide—Dyspepsia—Doxorubicin—sarcoma	0.000989	0.000989	CcSEcCtD
Gadodiamide—Fatigue—Doxorubicin—sarcoma	0.000968	0.000968	CcSEcCtD
Gadodiamide—Urticaria—Epirubicin—sarcoma	0.000964	0.000964	CcSEcCtD
Gadodiamide—Pain—Doxorubicin—sarcoma	0.000961	0.000961	CcSEcCtD
Gadodiamide—Abdominal pain—Epirubicin—sarcoma	0.00096	0.00096	CcSEcCtD
Gadodiamide—Body temperature increased—Epirubicin—sarcoma	0.00096	0.00096	CcSEcCtD
Gadodiamide—Feeling abnormal—Doxorubicin—sarcoma	0.000926	0.000926	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Doxorubicin—sarcoma	0.000919	0.000919	CcSEcCtD
Gadodiamide—Hypersensitivity—Epirubicin—sarcoma	0.000894	0.000894	CcSEcCtD
Gadodiamide—Urticaria—Doxorubicin—sarcoma	0.000892	0.000892	CcSEcCtD
Gadodiamide—Body temperature increased—Doxorubicin—sarcoma	0.000888	0.000888	CcSEcCtD
Gadodiamide—Abdominal pain—Doxorubicin—sarcoma	0.000888	0.000888	CcSEcCtD
Gadodiamide—Asthenia—Epirubicin—sarcoma	0.000871	0.000871	CcSEcCtD
Gadodiamide—Pruritus—Epirubicin—sarcoma	0.000859	0.000859	CcSEcCtD
Gadodiamide—Diarrhoea—Epirubicin—sarcoma	0.000831	0.000831	CcSEcCtD
Gadodiamide—Hypersensitivity—Doxorubicin—sarcoma	0.000828	0.000828	CcSEcCtD
Gadodiamide—Asthenia—Doxorubicin—sarcoma	0.000806	0.000806	CcSEcCtD
Gadodiamide—Dizziness—Epirubicin—sarcoma	0.000803	0.000803	CcSEcCtD
Gadodiamide—Pruritus—Doxorubicin—sarcoma	0.000795	0.000795	CcSEcCtD
Gadodiamide—Vomiting—Epirubicin—sarcoma	0.000772	0.000772	CcSEcCtD
Gadodiamide—Diarrhoea—Doxorubicin—sarcoma	0.000769	0.000769	CcSEcCtD
Gadodiamide—Rash—Epirubicin—sarcoma	0.000765	0.000765	CcSEcCtD
Gadodiamide—Dermatitis—Epirubicin—sarcoma	0.000765	0.000765	CcSEcCtD
Gadodiamide—Headache—Epirubicin—sarcoma	0.000761	0.000761	CcSEcCtD
Gadodiamide—Dizziness—Doxorubicin—sarcoma	0.000743	0.000743	CcSEcCtD
Gadodiamide—Nausea—Epirubicin—sarcoma	0.000721	0.000721	CcSEcCtD
Gadodiamide—Vomiting—Doxorubicin—sarcoma	0.000714	0.000714	CcSEcCtD
Gadodiamide—Rash—Doxorubicin—sarcoma	0.000708	0.000708	CcSEcCtD
Gadodiamide—Dermatitis—Doxorubicin—sarcoma	0.000708	0.000708	CcSEcCtD
Gadodiamide—Headache—Doxorubicin—sarcoma	0.000704	0.000704	CcSEcCtD
Gadodiamide—Nausea—Doxorubicin—sarcoma	0.000667	0.000667	CcSEcCtD
